Physician profile
Heather L Harmon
NPI 1801880513
$977.98
in general payments reported to CMS, 2019-2025
21 companies · $135 in 2025
The $135 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $92.63 · 2020: $84.31 · 2021: $147 · 2022: $128 · 2023: $180 · 2024: $211 · 2025: $135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $526.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $525.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $145.67 | 2022-2025 | Tyrvaya |
| Ocular Therapeutix, INC. | $108.77 | 2023-2025 | Dextenza |
| Alcon Vision LLC | $90.30 | 2019-2022 | |
| Aerie Pharmaceuticals, INC. | $88.83 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $83.19 | 2019-2023 | |
| Abbvie INC. | $62.59 | 2022-2024 | |
| Allergan, INC. | $52.30 | 2019-2021 | |
| Ani Pharmaceuticals, INC. | $45.01 | 2023-2024 | Purified Cortrophin Gel |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $37.86 | 2019-2021 | |
| Kala Pharmaceuticals, INC. | $36.51 | 2019-2020 | |
| Mallinckrodt Hospital Products INC. | $34.25 | 2023 | Acthar |
| Teva Pharmaceuticals USA, INC. | $33.82 | 2025 | Uzedy |
| Dompe US, INC. | $26.86 | 2024 | Oxervate |
| Bausch & Lomb Americas INC. | $24.95 | 2024 | Miebo, Xiidra |
| Tarsus Pharmaceuticals, INC. | $22.62 | 2024 | Xdemvy |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $22.19 | 2021 | |
| Harrow Eye, LLC | $18.30 | 2025 | Vevye |
| Eyevance Pharmaceuticals LLC | $15.48 | 2022 | |
| Lkc Technologies, INC. | $11.83 | 2025 | |
| Rxsight INC | $9.87 | 2022 | |
| Phathom Pharmaceuticals, INC. | $6.78 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Harmon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.